CLINICAL_TRIALS
trial_result
· 2024-02-12
Clinical Trial Update: Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology
Summary
Completed clinical trial assessing the prevalence and characteristics of transthyretin amyloidosis in patients with left ventricular hypertrophy of unknown etio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) | Status: COMPLETED | Results posted: 2024-02-12